Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Metabolize secures $3.2 million in seed financing to enhance metabolic health solutions. The funding, led by Astanor, will support the launch of NATLEAN and expand its product portfolio.

PRIVATEOct 15, 2026

Amount Raised

$3.2 Million

Round Type

Seed

San FranciscoBiotechnologyHealth Care

Investors

SosvLongGame VentureMaia VenturesAstanor

Description

Metabolize, a science-first consumer health company, announced the completion of its $3.2 million seed financing. The investment, led by Astanor, will accelerate commercialization of its Precision Metabolite™ Technology. Funds will also support continued development and manufacturing of its metabolic health products. Founded in 2024, Metabolize utilizes Stanford-originated research to create innovative solutions.

Company Information

Company

Metabolize

Location

San Francisco, California, United States

About

Metabolize is a science-first consumer health company built on Stanford Medicine-originated research. It develops Precision Metabolite™ Technology based on naturally occurring compounds with defined biological roles. The company aims to translate these patent-protected discoveries into consumer metabolic health products. Its first product, NATLEAN, is designed to support individuals transitioning off GLP-1 therapies.

Fundz sees it the moment Metabolize raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Metabolize's next move

See what Strategic adds

Metabolize raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.